Scientists at Stanford have developed a new PET scan tracer that flags both pancreatic cancer and a lung disease known as idiopathic pulmonary fibrosis.
A Stanford biomedical data scientist discusses how computational modeling of big data could help improve personalized chemotherapy selection in the future.
As physician Ilana Yurkiewicz writes, it can be challenging to treat a patient with a hematological emergency who is concerned about the cost of care.
Certain brain tumors wire themselves into the brain's electrical communication network, a new Stanford-led study has shown.
A team of Stanford scientists have devised a new imaging technology that harnesses ultrasound and photoacoustics to detect prostate cancer earlier.
The Myc oncogene helps cancer cells stockpile the fat, or lipids, necessary for rapid growth. Blocking this activity causes human tumors in mice to shrink.
Scientists have used CRISPR-Cas9 gene editing technology to decipher the genes critical to the success of a type of cancer drug, antibody-drug conjugates.
In this In the Spotlight, hematologist/oncologist Gabriel Mannis talks about his passion for medicine and his experience working at Sesame Street.
A new clinic at Stanford Health Care for cancer survivors is designed to integrate primary care with health after cancer.
Stanford researcher Eleni Linos turned to social media to see if it was a more effective way to spread information about skin cancer and tanning to youth.
Pioneering immunotherapy drug Provenge is enjoying a revival, thanks to a large new clinical trial that will test it in men with early prostate cancer.
On Stanford Radio's The Future of Everything, neurooncologist Michelle Monje discussed developments in the treatment of brain cancer in children.
Stanford clinicians take their cue from sports and election predictions to calculate an "in-game probability" of success when treating cancer patients.
Stanford researchers develop a machine-learning computer model for mammography assessment in hopes of aiding radiologists’ clinical decisions.
Many metastatic colorectal cancers appear "born to be bad," spreading to other organs before any diagnosis has been made, say Stanford researchers.
A patient worried that cancer may run in her family finds answers through genetic testing offering by Stanford Medicine's Humanwide project.